Added to YB: 2025-01-02
Pitch date: 2024-12-24
TEM [bullish]
Tempus AI, Inc.
+103.6%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
Market Cap
$12.5B
Pitch Price
$34.68
Price Target
104.37 (+48%)
Dividend
N/A
EV/EBITDA
-82.74
P/E
-59.11
EV/Sales
11.84
Sector
Life Sciences Tools and Services
Category
growth
Why Tempus AI (TEM) is Poised for Multi-Year Growth and Market Leadership
TEM: Adding to position. Diagnostics biz taking share, leveraging database for personalized treatment. Multi-modal data biz key differentiator: robust RWD dataset + app layer for pharma R&D. $280B pharma R&D spend, potential for billions in rev. 25-30% growth, inflecting profitability. 6x CY25 rev too cheap, 5x+ likely.
Read full article (2 min)